I wouldn't view it as all negative! Multicentre site means broadening of this study, this could play very well for us over the longer term.
- Forums
- ASX - By Stock
- PAR
- Ann: Phase 2 Synovial Fluid Biomarker Study Update
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.22%
!
40.5¢

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
40.5¢ |
Change
-0.005(1.22%) |
Mkt cap ! $160.9M |
Open | High | Low | Value | Volume |
40.0¢ | 41.0¢ | 40.0¢ | $87.37K | 216.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 13980 | 40.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.0¢ | 3900 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 13980 | 0.405 |
7 | 41141 | 0.400 |
9 | 138655 | 0.395 |
5 | 48582 | 0.390 |
7 | 121792 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.410 | 2100 | 1 |
0.415 | 12532 | 5 |
0.420 | 60349 | 7 |
0.425 | 14600 | 5 |
0.430 | 32400 | 3 |
Last trade - 11.45am 18/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |